UPDATED Apr 30, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CHKP | US$149.42 | -7.1% | 23.7% | US$16.9b | US$172.01 | PE20.1x | E3.9% | n/a | ||
AKAM | US$100.93 | -0.8% | 27.8% | US$15.5b | US$127.19 | PE28.2x | E13.7% | n/a | ||
DT | US$45.31 | -2.0% | 9.7% | US$13.8b | US$62.19 | PE68.1x | E18.5% | n/a | ||
EPAM | US$235.26 | -5.1% | -13.1% | US$13.6b | US$306.59 | PE32.7x | E13.5% | n/a | ||
GEN | US$20.14 | -2.6% | 19.0% | US$12.8b | US$26.11 | PE9.2x | E7.0% | 2.5% | ||
MANH | US$206.06 | -10.7% | 22.9% | US$12.7b | US$238.43 | PE66.2x | E13.2% | n/a | ||
DOCU | US$56.60 | -0.2% | 16.8% | US$11.6b | US$65.75 | PE156.6x | E27.6% | n/a | ||
ESTC | US$102.22 | -0.3% | 86.0% | US$10.5b | US$132.58 | PE183.7x | E-32.0% | n/a |